Previous close | 51.70 |
Open | 51.70 |
Bid | 47.70 |
Ask | 51.40 |
Strike | 165.00 |
Expiry date | 2024-05-17 |
Day's range | 51.70 - 51.70 |
Contract range | N/A |
Volume | |
Open interest | N/A |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.